Top Markets
#1 Arowana Arowana +36.44%
#2 Fabric Protocol Fabric Protocol +31.78%
#3 The Black Bull The Black Bull +30.12%
#4 Tutorial Tutorial +28.38%
#5 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +28.31%
#6 Bitcoin Cash Bitcoin Cash +27.26%
#7 Ethena Staked ENA Ethena Staked ENA +26.40%
#8 aPriori aPriori +25.87%
#9 RedStone RedStone +25.11%
#10 Talus Network Talus Network +23.67%
Coin of the day
Arowana Arowana
Settings
Language
ENGLISH
Currency
USD
Theme
Venus Medtech (Hangzhou) Inc. Venus Medtech (Hangzhou) Inc.

Venus Medtech (Hangzhou) Inc.

2500
Rank in Stocks #24713
Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the... Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of bioprosthetic heart valves in Mainland China and internationally. The company’s offers transcatheter aortic heart valve replacement products, such as VenusA-Valve, VenusA-Plus, VenusA-Pro, and VenusA-Deluxe; and VenusP-Valve, a transcatheter pulmonary valve system to treat the patients suffering with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract stenosis. It also develops Venus-Vitae, a balloon-expandable dry-tissue product; Venus-PowerX, a self-expanding dry-tissue product; Cardiovalve, a transcatheter valve replacement system for the treatment of patients with mitral regurgitation and in pivotal clinical trial for the treatment of patients with tricuspid regurgitation; Liwen RF, a radiofrequency ablation system for the treatment of hypertrophic cardiomyopathy; and renal artery denervation ablation system for the treatment of hypertension. In addition, the company offers procedural accessories comprising catheter sheath product and balloon catheter. Venus Medtech (Hangzhou) Inc. was incorporated in 2009 and is headquartered in Hangzhou, the People’s Republic of China.
Share Price
$0.13048475
Market Cap
$57.55M
Change (1 day)
-1.92%
Change (1 year)
-77.88%
Country
CN
Trade Venus Medtech (Hangzhou) Inc. (2500)

Category

Healthcare
Operating Margin for Venus Medtech (Hangzhou) Inc. (2500)
Operating Margin as of 2026 TTM: 0.00%
According to Venus Medtech (Hangzhou) Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Venus Medtech (Hangzhou) Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
STERIS plc STERIS plc
STERIS plc
STE.US
18.91% -
IE
Shanghai United Imaging Healthcare Co., Ltd. Shanghai United Imaging Healthcare Co., Ltd.
Shanghai United Imaging Healthcare Co., Ltd.
688271.SS
0.00% -
CN
Ypsomed Holding AG Ypsomed Holding AG
Ypsomed Holding AG
YPSN.SW
0.00% -
CH
Medacta Group S.A. Medacta Group S.A.
Medacta Group S.A.
MOVE.SW
0.00% -
CH
Jafron Biomedical Co.,Ltd. Jafron Biomedical Co.,Ltd.
Jafron Biomedical Co.,Ltd.
300529.SZ
0.00% -
CN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.